← boothcheck

Is BUD overvalued?

boothcheck doesn't label BUD overvalued or undervalued and publishes no house fair value, target price, or buy/sell rating. Individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. In the published model solve dated 2026-08-30T04:06:24.299Z, anchored at $80.13, the BUD price sits below the model's tested range at its stated assumptions: even the steepest tested decline path leaves model value above the price, and the exact break-even path was not resolved. The price is supported by earnings-power and relative-multiple and growth-DCF value, while asset-based lands below the price. A value/asset-supported name, not a pure growth bet. The report narrative was composed 2026-07-25. The more the price assumes beyond what Anheuser-Busch InBev SA/NV has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Anheuser-Busch InBev SA/NV's SEC EDGAR filings via a reverse-DCF inversion. Last analyzed July 25, 2026.

Model readbeyond tested decline range
Price vs asset value1.57x
Price vs earnings power1.09x
Price vs peer multiples1.21x
Price vs forward growth0.96x
Read the full BUD report →
Get boothcheck's read on what BUD's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.